DiaMedica Therapeutics
Price & Volume
Stats
See more52W Range | $3.19-$6.81 |
Market Cap | $179.2M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • yesterday
DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright
Yahoo Finance • 2 days ago
DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia
Yahoo Finance • 2 days ago
DiaMedica reports positive interim results for preeclampsia treatment
Yahoo Finance • 25 days ago
DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes
About
CEO | Mr. Dietrich John Pauls MBA |
CFO | Mr. Scott Kellen CPA |
Address | 301 Carlson Parkway, Minneapolis, MN, United States, 55305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |
